Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $10.53 and last traded at $10.66, with a volume of 1213406 shares trading hands. The stock had previously closed at $10.71.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on RBGLY shares. Sanford C. Bernstein upgraded Reckitt Benckiser Group from a "market perform" rating to an "outperform" rating in a research note on Monday, December 11th. Jefferies Financial Group downgraded Reckitt Benckiser Group from a "hold" rating to an "underperform" rating in a research note on Monday, December 11th. Finally, BNP Paribas upgraded Reckitt Benckiser Group from an "underperform" rating to a "neutral" rating in a research note on Tuesday, January 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, Reckitt Benckiser Group currently has an average rating of "Hold" and an average target price of $6,978.00.
Get Our Latest Stock Analysis on RBGLY
Reckitt Benckiser Group Stock Performance
The stock has a 50 day moving average of $13.31 and a 200-day moving average of $13.67.
Reckitt Benckiser Group Increases Dividend
The firm also recently declared a dividend, which will be paid on Monday, June 3rd. Investors of record on Friday, April 12th will be issued a $0.2701 dividend. The ex-dividend date is Thursday, April 11th. This is a boost from Reckitt Benckiser Group's previous dividend of $0.18.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.
Featured Stories
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
